Sildenafil

Sildenafil, widely recognized by its brand name Viagra, is a pharmaceutical compound initially developed for circulatory issues and later gaining prominence as a treatment for erectile dysfunction. Recent scientific investigations, notably by researchers at the Weizmann Institute of Science, suggest sildenafil may play a role in inhibiting cancer metastasis through a newly identified biological mechanism. This discovery highlights a potential new therapeutic application beyond its established uses. Concurrently, regulatory bodies are addressing concerns regarding the illicit presence of sildenafil in products marketed as food supplements. The Spanish Agency of Medicines and Health Products (AEMPS) has reported the withdrawal of a product containing undeclared sildenafil, emphasizing that the drug is contraindicated for certain individuals and can interact with other medications. These developments underscore sildenafil's evolving medical relevance, from its original indications to emerging cancer research and the ongoing need for regulatory oversight to ensure public safety.